A metabolomics investigation into the effects of HIV protease inhibitors on HPV16 E6 expressing cervical carcinoma cells
Autor: | Yun Xu, Dong-Hyun Kim, J. William Allwood, Rowan E. Moore, Emma Marsden-Edwards, Royston Goodacre, Warwick B. Dunn, Lynne Hampson, Ian N. Hampson |
---|---|
Rok vydání: | 2014 |
Předmět: |
Drug
Metabolite media_common.quotation_subject Gene Expression Uterine Cervical Neoplasms Pharmacology Biology Transfection 01 natural sciences 03 medical and health sciences chemistry.chemical_compound Metabolomics Indinavir Cell Line Tumor Mass Spectrometry HPV Lopinavir HIV Protease Inhibitors Cervical Cancer medicine Metabolome HIV Protease Inhibitor Humans Molecular Biology 030304 developmental biology media_common 0303 health sciences 010401 analytical chemistry Carcinoma Lopinavir HIV Protease Inhibitors Oncogene Proteins Viral 3. Good health 0104 chemical sciences Repressor Proteins chemistry Female Biotechnology medicine.drug |
Zdroj: | Kim, D H, Allwood, J W, Moore, R E, Marsden-Edwards, E, Dunn, W B, Xu, Y, Hampson, L, Hampson, I & Goodacre, R 2014, ' A metabolomics investigation into the effects of HIV protease inhibitors on HPV16 E6 expressing cervical carcinoma cells. ', Molecular BioSystems, vol. 10, no. 3, pp. 398-411 . https://doi.org/10.1039/C3MB70423H |
ISSN: | 1742-2051 |
DOI: | 10.1039/C3MB70423H |
Popis: | Recently, it has been reported that anti-viral drugs, such as indinavir and lopinavir (originally targeted for HIV), also inhibit E6-mediated proteasomal degradation of mutant p53 in E6-transfected C33A cells. In order to understand more about the mode-of-action(s) of these drugs the metabolome of HPV16 E6 expressing cervical carcinoma cell lines was investigated using mass spectrometry (MS)-based metabolic profiling. The metabolite profiling of C33A parent and E6-transfected cells exposed to these two anti-viral drugs was performed by ultra performance liquid chromatography (UPLC)-MS and gas chromatography (GC)-time of flight (TOF)-MS. Using a combination of univariate and multivariate analyses, these metabolic profiles were investigated for analytical and biological reproducibility and to discover key metabolite differences elicited during anti-viral drug challenge. This approach revealed both distinct and common effects of these two drugs on the metabolome of two different cell lines. Finally, intracellular drug levels were quantified, which suggested in the case of lopinavir that increased activity of membrane transporters may contribute to the drug sensitivity of HPV infected cells. |
Databáze: | OpenAIRE |
Externí odkaz: |